Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,479

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies

Ackerman, Michael J., Priori, Silvia G., Willems, Stephan, Berul, Charles, Brugada, Ramon, Calkins, Hugh, Camm, A. John, Ellinor, Patrick T., Gollob, Michael, Hamilton, Robert, Hershberger, Ray E., Judge, Daniel P., Le Marec, Hervè, McKenna, William J., Schulze-Bahr, Eric, Semsarian, Chris, Towbin, Jeffrey A., Watkins, Hugh, Wilde, Arthur, Wolpert, Christian, Zipes, Douglas P.·2011·Heart Rhythm
DOI 10.1016/j.hrthm.2011.05.020
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.hrthm.2011.05.020

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 264

  1. Liebman, 2001, Some legal, social, and ethical issues related to the genetic testing revolution, as exemplified in the long QT syndrome, J Electrocardiol, 34, 183, 10.1054/jelc.2001.28866 · DOI
  2. Nelson, 2001, (Committee on Bioethics), Pediatrics, 107, 1451
  3. Hendriks, 2008, Familial disease with a risk on sudden death: a longitudinal study of the psychological consequences of predictive testing for Long QT syndrome, Heart Rhythm, 5, 719, 10.1016/j.hrthm.2008.01.032 · DOI
  4. Christiaans, 2009, Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study, Am J Med Genet, 149A, 602, 10.1002/ajmg.a.32710 · DOI
  5. Tester, 2011, Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice, Circulation, 123, 1021, 10.1161/CIRCULATIONAHA.109.914838 · DOI
  6. Napolitano, 2005, Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice, Jama, 294, 2975, 10.1001/jama.294.23.2975 · DOI · Paper page
  7. Hofman, 2010, Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment?, J Am Coll Cardiol, 55, 2570, 10.1016/j.jacc.2009.12.063 · DOI
  8. Ackerman, 2003, Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome, Mayo Clin Proc, 78, 1479, 10.4065/78.12.1479 · DOI · Paper page
  9. Ackerman, 2004, Spectrum and prevalence of cardiac sodium channel variants among Black, White, Asian, Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/Long QT syndrome genetic testing, Heart Rhythm, 1, 600, 10.1016/j.hrthm.2004.07.013 · DOI · Paper page
  10. Kapa, 2009, Genetic testing for long QT syndrome—distinguishing pathogenic mutations from benign variants, Circulation, 120, 1752, 10.1161/CIRCULATIONAHA.109.863076 · DOI · Paper page
  11. Kapplinger, 2011, Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise, J Am Coll Cardiol, 57, 2317, 10.1016/j.jacc.2010.12.036 · DOI · Paper page
  12. Priori, 1999, Low penetrance in the long-QT syndrome: clinical impact, Circulation, 99, 529, 10.1161/01.CIR.99.4.529 · DOI · Paper page
  13. Tester, 2006, Effect of clinical phenotype on yield of long QT syndrome genetic testing, J Am Coll Cardiol, 47, 764, 10.1016/j.jacc.2005.09.056 · DOI
  14. Vincent, 1992, The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome, N Engl J Med, 327, 846, 10.1056/NEJM199209173271204 · DOI · Paper page
  15. Priori, 2003, Risk stratification in the long-QT syndrome, N Engl J Med, 348, 1866, 10.1056/NEJMoa022147 · DOI · Paper page
  16. Vyas, 2006, Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response, Circulation, 113, 1385, 10.1161/CIRCULATIONAHA.105.600445 · DOI
  17. Takenaka, 2003, Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome, Circulation, 107, 838, 10.1161/01.CIR.0000048142.85076.A2 · DOI · Paper page
  18. Shimizu, 2004, Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome, Heart Rhythm, 1, 276, 10.1016/j.hrthm.2004.04.021 · DOI
  19. Krahn, 2005, Diagnosis of unexplained cardiac arrest: role of adrenaline and procainamide infusion, Circulation, 112, 2228, 10.1161/CIRCULATIONAHA.105.552166 · DOI
  20. Viskin, 2010, The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome, J Am Coll Cardiol, 55, 1955, 10.1016/j.jacc.2009.12.015 · DOI
  21. Schwartz, 1993, Diagnostic criteria for the long QT syndrome, Circulation, 88, 782, 10.1161/01.CIR.88.2.782 · DOI · Paper page
  22. Schwartz, 2009, Prevalence of the congenital long-QT syndrome, Circulation, 120, 1761, 10.1161/CIRCULATIONAHA.109.863209 · DOI · Paper page
  23. Goldenberg, 2008, Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome, Circulation, 117, 2184, 10.1161/CIRCULATIONAHA.107.701243 · DOI · Paper page
  24. Hobbs, 2006, Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome, Jama, 296, 1249, 10.1001/jama.296.10.1249 · DOI · Paper page
  25. Monnig, 2006, Electrocardiographic risk stratification in families with congenital long QT syndrome, Eur Heart J, 27, 2074, 10.1093/eurheartj/ehl159 · DOI
  26. Sauer, 2007, Long QT syndrome in adults, J Am Coll Cardiol, 49, 329, 10.1016/j.jacc.2006.08.057 · DOI · Paper page
  27. Jons, 2010, Risk of fatal arrhythmic events in long QT syndrome patients after syncope, J Am Coll Cardiol, 55, 783, 10.1016/j.jacc.2009.11.042 · DOI · Paper page
  28. Wang, 1995, SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome, Cell, 80, 805, 10.1016/0092-8674(95)90359-3 · DOI · Paper page
  29. Schwartz, 1985, Idiopathic long QT syndrome: progress and questions, Am Heart J, 109, 399, 10.1016/0002-8703(85)90626-X · DOI · Paper page
  30. Curran, 1995, A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome, Cell, 80, 795, 10.1016/0092-8674(95)90358-5 · DOI · Paper page
  31. Wang, 1996, Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias, Nat Genet, 12, 17, 10.1038/ng0196-17 · DOI · Paper page
  32. Abbott, 1999, MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia, Cell, 97, 175, 10.1016/S0092-8674(00)80728-X · DOI · Paper page
  33. Plaster, 2001, Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome, Cell, 105, 511, 10.1016/S0092-8674(01)00342-7 · DOI · Paper page
  34. Vatta, 2006, Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome, Circulation, 114, 2104, 10.1161/CIRCULATIONAHA.106.635268 · DOI · Paper page
  35. Medeiros-Domingo, 2007, SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome, Circulation, 116, 134, 10.1161/CIRCULATIONAHA.106.659086 · DOI · Paper page
  36. Ueda, 2008, Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex, Proc Natl Acad Sci U S A, 105, 9355, 10.1073/pnas.0801294105 · DOI · Paper page
  37. Yang, 2010, Identification of a Kir3.4 mutation in congenital long QT syndrome, Am J Hum Genet, 86, 872, 10.1016/j.ajhg.2010.04.017 · DOI
  38. Priori, 1999, Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part III, Circulation, 99, 674, 10.1161/01.CIR.99.5.674 · DOI
  39. Eddy, 2008, Identification of large gene deletions and duplications in KCNQ1 and KCNH2 in patients with long QT syndrome, Heart Rhythm, 5, 1275, 10.1016/j.hrthm.2008.05.033 · DOI
  40. Tester DJ, Benton AJ, Train L, et al. Prevalence and spectrum of large deletions or duplications in the major long QT syndrome-susceptibility genes and implications for long QT syndrome genetic testing. Am J Cardiol;106:1124–1128. · DOI
  41. Goldenberg, 2006, Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome, J Cardiovasc Electrophysiol, 17, 1161, 10.1111/j.1540-8167.2006.00587.x · DOI
  42. Schwartz, 2006, The Jervell and Lange-Nielsen syndrome, Circulation, 113, 783, 10.1161/CIRCULATIONAHA.105.592899 · DOI · Paper page
  43. Kapplinger, 2009, Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test, Heart Rhythm, 6, 1297, 10.1016/j.hrthm.2009.05.021 · DOI · Paper page
  44. Schwartz, 2006, The congenital long QT syndromes from genotype to phenotype: clinical implications, J Intern Med, 259, 39, 10.1111/j.1365-2796.2005.01583.x · DOI
  45. Taggart, 2007, Diagnostic miscues in congenital long-QT syndrome, Circulation, 115, 2613, 10.1161/CIRCULATIONAHA.106.661082 · DOI
  46. Napolitano, 2005, Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice, Jama, 294, 2975, 10.1001/jama.294.23.2975 · DOI · Paper page
  47. Medeiros-Domingo, 2009, J Am Coll Cardiol, 54, 2065, 10.1016/j.jacc.2009.08.022 · DOI · Paper page
  48. Tester, 2005, Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing, Heart Rhythm, 2, 1099, 10.1016/j.hrthm.2005.07.012 · DOI
  49. Kapa, 2009, Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants, Circulation, 120, 1752, 10.1161/CIRCULATIONAHA.109.863076 · DOI · Paper page
  50. Rautaharju, 2009, AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval, J Am Coll Cardiol, 53, 982, 10.1016/j.jacc.2008.12.014 · DOI · Paper page
  51. Schwartz, 2010, Repolarization abnormalities in the newborn, J Cardiovasc Pharmacol, 55, 539, 10.1097/FJC.0b013e3181d86525 · DOI
  52. Yang, 2002, Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes, Circulation, 105, 1943, 10.1161/01.CIR.0000014448.19052.4C · DOI · Paper page
  53. Paulussen, 2004, Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients, J Mol Med, 82, 182, 10.1007/s00109-003-0522-z · DOI · Paper page
  54. Lehtonen, 2007, Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes, Heart Rhythm, 4, 603, 10.1016/j.hrthm.2007.01.019 · DOI
  55. Zhang, 2000, Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes, Circulation, 102, 2849, 10.1161/01.CIR.102.23.2849 · DOI · Paper page
  56. Schwartz, 2001, Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias, Circulation, 103, 89, 10.1161/01.CIR.103.1.89 · DOI · Paper page
  57. Ackerman, 1998, The long QT syndrome, Pediatr Rev, 19, 232, 10.1542/pir.19-7-232 · DOI
  58. Choi, 2004, Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes, Circulation, 110, 2119, 10.1161/01.CIR.0000144471.98080.CA · DOI · Paper page
  59. Moss, 2007, Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene, Circulation, 115, 2481, 10.1161/CIRCULATIONAHA.106.665406 · DOI · Paper page
  60. Shimizu, 2009, Genotype-phenotype aspects of type 2 long QT syndrome, J Am Coll Cardiol, 54, 2052, 10.1016/j.jacc.2009.08.028 · DOI · Paper page
  61. Crotti, 2007, The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification, Circulation, 116, 2366, 10.1161/CIRCULATIONAHA.107.726950 · DOI
  62. Makita, 2008, The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome, J Clin Invest, 118, 2219
  63. Villain, 2004, Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome, Eur Heart J, 25, 1405, 10.1016/j.ehj.2004.06.016 · DOI
  64. Monnig, 2005, Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up, Heart Rhythm, 2, 497, 10.1016/j.hrthm.2005.02.008 · DOI
  65. Schwartz, 2010, Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?, Circulation, 122, 1272, 10.1161/CIRCULATIONAHA.110.950147 · DOI · Paper page
  66. Horner, 2010, Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience, Heart Rhythm, 7, 1616, 10.1016/j.hrthm.2010.08.023 · DOI
  67. Moss, 2000, Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome, Circulation, 101, 616, 10.1161/01.CIR.101.6.616 · DOI · Paper page
  68. Schwartz, 1995, Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate, Circulation, 92, 3381, 10.1161/01.CIR.92.12.3381 · DOI · Paper page
  69. Ruan, 2007, Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients, Circulation, 116, 1137, 10.1161/CIRCULATIONAHA.107.707877 · DOI
  70. Moss, 2005, Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial, Ann Noninvasive Electrocardiol, 10, 59, 10.1111/j.1542-474X.2005.00077.x · DOI
  71. Coumel, 1978, Catecholaminergic-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases, Br Heart J, 40, 28
  72. Leenhardt, 1995, Catecholaminergic polymorphic ventricular tachycardia in children, Circulation, 91, 1512, 10.1161/01.CIR.91.5.1512 · DOI · Paper page
  73. Priori, 2002, Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia, Circulation, 106, 69, 10.1161/01.CIR.0000020013.73106.D8 · DOI · Paper page
  74. Priori, 2001, Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia, Circulation, 103, 196, 10.1161/01.CIR.103.2.196 · DOI · Paper page
  75. Bai, 2009, Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing, Circ Arrhythm Electrophysiol, 2, 6, 10.1161/CIRCEP.108.782888 · DOI
  76. George, 2007, Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies, J Mol Cell Cardiol, 42, 34, 10.1016/j.yjmcc.2006.08.115 · DOI
  77. Raffaele di Barletta, 2006, Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia, Circulation, 114, 1012, 10.1161/CIRCULATIONAHA.106.623793 · DOI
  78. Tester, 2007, A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors, Heart Rhythm, 4, 733, 10.1016/j.hrthm.2007.02.026 · DOI
  79. Tristani-Firouzi, 2002, Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome), J Clin Invest, 110, 381, 10.1172/JCI15183 · DOI · Paper page
  80. Mohler, 2004, A cardiac arrhythmia syndrome caused by loss of ankyrin-B function, Proc Natl Acad Sci U S A, 101, 9137, 10.1073/pnas.0402546101 · DOI · Paper page
  81. Brugada, 1992, Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome, J Am Coll Cardiol, 20, 1391, 10.1016/0735-1097(92)90253-J · DOI · Paper page
  82. Antzelevitch, 2005, Brugada syndrome, Heart Rhythm, 2, 429, 10.1016/j.hrthm.2005.01.005 · DOI · Paper page
  83. Fowler, 2009, Clinical Spectrum of patients with a Brugada ECG, Curr Opin Cardiol, 24, 74, 10.1097/HCO.0b013e32831cb920 · DOI
  84. Gehi, 2006, Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis, J Cardiovasc Electrophysiol, 17, 577, 10.1111/j.1540-8167.2006.00455.x · DOI · Paper page
  85. Priori, 2002, Natural history of Brugada syndrome: insights for risk stratification and management, Circulation, 105, 1342, 10.1161/hc1102.105288 · DOI · Paper page
  86. Paul, 2007, Role of programmed ventricular stimulation in patients with Brugada syndrome—a meta-analysis of worldwide published data, Eur Heart J, 28, 2126, 10.1093/eurheartj/ehm116 · DOI
  87. Brugada, 2003, Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart, J Cardiovasc Electrophysiol, 14, 455, 10.1046/j.1540-8167.2003.02517.x · DOI
  88. Viskin, 2009, Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry, Heart Rhythm, 6, 401, 10.1016/j.hrthm.2008.11.030 · DOI
  89. Kapplinger, 2010, An international compendium of mutation in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing, Heart Rhythm, 1, 33, 10.1016/j.hrthm.2009.09.069 · DOI · Paper page
  90. Smits, 2002, Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non SCN5A related patients, J Am Coll Cardiol, 40, 350, 10.1016/S0735-1097(02)01962-9 · DOI · Paper page
  91. Meregalli, 2009, Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies, Heart Rhythm, 6, 341, 10.1016/j.hrthm.2008.11.009 · DOI
  92. Postema, 2009, Drugs and Brugada syndrome patients: review of the literature, recommendations and an up-to-date website, Heart Rhythm, 6, 1335, 10.1016/j.hrthm.2009.07.002 · DOI · Paper page
  93. Probst, 2003, Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenegre disease, J Am Coll Cardiol, 41, 643, 10.1016/S0735-1097(02)02864-4 · DOI
  94. Brink, 1977, Progressive familial heart block—two types, S Afr Med J, 52, 53
  95. Postema, 2009, Founder mutations in the Netherlands: SCN5a 1795insD, the first described arrhythmia overlap syndrome and one of the largest and best characterised families worldwide, Neth Heart J, 17, 422, 10.1007/BF03086296 · DOI
  96. Benson, 2003, Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A), J Clin Invest, 112, 1019, 10.1172/JCI200318062 · DOI · Paper page
  97. Schott, 1998, Congenital heart disease caused by mutations in the transcription factor NKX2-5, Science, 281, 108, 10.1126/science.281.5373.108 · DOI · Paper page
  98. Paul, 2009, Genes causing inherited forms of cardiomyopathies, Herz, 34, 98, 10.1007/s00059-009-3215-8 · DOI
  99. Bezzina, 2003, Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system, Circ Res, 92, 159, 10.1161/01.RES.0000052672.97759.36 · DOI
  100. Neu, 2010, A homozygous SCN5A mutation in a severe, recessive type of cardiac conduction disease, Hum Mutat, 31, E1609, 10.1002/humu.21302 · DOI
  101. Schott, 1999, Cardiac conduction defects associate with mutations in SCN5A, Nat Genet, 23, 20, 10.1038/12618 · DOI · Paper page
  102. Tan, 2001, A sodium-channel mutation causes isolated cardiac conduction disease, Nature, 409, 1043, 10.1038/35059090 · DOI · Paper page
  103. Watanabe, 2008, Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans, J Clin Invest, 118, 2260
  104. Kruse, 2009, Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I, J Clin Invest, 119, 2737, 10.1172/JCI38292 · DOI · Paper page
  105. Liu, 2010, Gain-of-function mutations in TRPM4 cause autosomal dominant isolated cardiac conduction disease, Circ Cardiovasc Genet, 3, 374, 10.1161/CIRCGENETICS.109.930867 · DOI
  106. Schulze-Bahr, 2001, A mutation in the cardiac pacemaker channel gene hHCN4 is linked to human sinus node disease, Am J Hum Genet, 69, 183
  107. Milanesi, 2006, Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel, N Engl J Med, 354, 151, 10.1056/NEJMoa052475 · DOI · Paper page
  108. Garg, 2003, GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5, Nature, 424, 443, 10.1038/nature01827 · DOI · Paper page
  109. Spaendonck-Zwarts, 2010, Desmin-related myopathy: a review and meta-analysis, Clin Genet
  110. Perrot, 2009, Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy, Basic Res Cardiol, 104, 90, 10.1007/s00395-008-0748-6 · DOI
  111. van Tintelen, 2007, High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics, Am Heart J, 154, 1130, 10.1016/j.ahj.2007.07.038 · DOI
  112. McNair, 2004, SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia, Circulation, 110, 2163, 10.1161/01.CIR.0000144458.58660.BB · DOI · Paper page
  113. Hesse, 2007, Dilated cardiomyopathy is associated with reduced expression of the cardiac sodium channel Scn5a, Cardiovasc Res, 75, 498, 10.1016/j.cardiores.2007.04.009 · DOI
  114. Olson, 2005, Sodium channel mutations and susceptibility to heart failure and atrial fibrillation, Jama, 293, 447, 10.1001/jama.293.4.447 · DOI · Paper page
  115. Shi, 2008, The cardiac sodium channel mutation delQKP 1507-1509 is associated with the expanding phenotypic spectrum of LQT3, conduction disorder, dilated cardiomyopathy, and high incidence of youth sudden death, Europace, 10, 1329, 10.1093/europace/eun202 · DOI
  116. Ackerman, 2004, Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing, Heart Rhythm, 1, 600, 10.1016/j.hrthm.2004.07.013 · DOI · Paper page
  117. Epstein, 2008, ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary, Heart Rhythm, 5, 934, 10.1016/j.hrthm.2008.04.015 · DOI · Paper page
  118. Gussak, 2000, Idiopathic short QT interval: a new clinical syndrome?, Cardiology, 94, 99, 10.1159/000047299 · DOI · Paper page
  119. Rhodes, 2008, Cardiac potassium channel dysfunction in sudden infant death syndrome, J Mol Cell Cardiol, 44, 571, 10.1016/j.yjmcc.2007.11.015 · DOI
  120. Anttonen, 2007, Prevalence and prognostic significance of short QT-interval in a middle-aged Finnish population, Circulation, 116, 714, 10.1161/CIRCULATIONAHA.106.676551 · DOI
  121. Funada, 2008, Assessment of QT-intervals and prevalence of Short QT syndrome in Japan, Clin Cardiol, 31, 270, 10.1002/clc.20208 · DOI
  122. Mason, 2007, Electrocardiographic reference ranges derived from 79,743 ambulatory subjects, J Electrocardiol, 40, 228, 10.1016/j.jelectrocard.2006.09.003 · DOI · Paper page
  123. Kobza, 2009, Prevalence of long and short QT in a young population of 41,767 predominantly male Swiss conscripts, Heart Rhythm, 6, 652, 10.1016/j.hrthm.2009.01.009 · DOI
  124. Gollob, 2011, The short QT syndrome: proposed diagnostic criteria, J Am Coll Cardiol, 57, 802, 10.1016/j.jacc.2010.09.048 · DOI · Paper page
  125. Schimpf, 2003, Congenital Short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery, J Cardiovasc Electrophysiol, 14, 1273, 10.1046/j.1540-8167.2003.03278.x · DOI
  126. Viskin, 2004, Is idiopathic ventricular fibrillation a short QT syndrome?, Heart Rhythm, 1, 587, 10.1016/j.hrthm.2004.07.010 · DOI
  127. Wolpert, 2005, Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG, J Cardiovasc Electrophysiol, 16, 54, 10.1046/j.1540-8167.2005.04470.x · DOI
  128. Gaita, 2004, Short QT syndrome: pharmacological treatment, J Am Coll Cardiol, 43, 1494, 10.1016/j.jacc.2004.02.034 · DOI · Paper page
  129. Cordeiro, 2005, Modulation of Ikr inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome, Cardiovasc Res, 67, 498, 10.1016/j.cardiores.2005.02.018 · DOI
  130. Bellocq, 2004, Mutation in the KCNQ1 gene leading to the short QT-interval syndrome, Circulation, 109, 2394, 10.1161/01.CIR.0000130409.72142.FE · DOI · Paper page
  131. Hong, 2005, De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero, Cardiovasc Res, 68, 433, 10.1016/j.cardiores.2005.06.023 · DOI · Paper page
  132. Priori, 2005, A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene, Circ Res, 96, 800, 10.1161/01.RES.0000162101.76263.8c · DOI · Paper page
  133. Hong, 2005, Short QT syndrome et atrial fibrillation caused by mutation in KCNH2, J Cardiovas Electrophysiol, 16, 394, 10.1046/j.1540-8167.2005.40621.x · DOI · Paper page
  134. Antzelevitch, 2007, Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT-intervals, and sudden cardiac death, Circulation, 115, 442, 10.1161/CIRCULATIONAHA.106.668392 · DOI · Paper page
  135. Lubitz, 2010, Association between familial atrial fibrillation and risk of new-onset atrial fibrillation, Jama, 304, 2263, 10.1001/jama.2010.1690 · DOI · Paper page
  136. Chen, 2003, Kcnq1 gain-of-function mutation in familial atrial fibrillation, Science, 299, 251, 10.1126/science.1077771 · DOI · Paper page
  137. Das, 2009, Mutation in the s3 segment of kcnq1 results in familial lone atrial fibrillation, Heart Rhythm, 6, 1146, 10.1016/j.hrthm.2009.04.015 · DOI
  138. Xia, 2005, A kir2.1 gain-of-function mutation underlies familial atrial fibrillation, Biochem Biophys Res Commun, 332, 1012, 10.1016/j.bbrc.2005.05.054 · DOI · Paper page
  139. Yang, 2004, Identification of a kcne2 gain-of-function mutation in patients with familial atrial fibrillation, Am J Hum Genet, 75, 899, 10.1086/425342 · DOI · Paper page
  140. Makiyama, 2008, A novel scn5a gain-of-function mutation m1875t associated with familial atrial fibrillation, J Am Coll Cardiol, 52, 1326, 10.1016/j.jacc.2008.07.013 · DOI
  141. Olson, 2006, Kv1.5 channelopathy due to kcna5 loss-of-function mutation causes human atrial fibrillation, Hum Mol Genet, 15, 2185, 10.1093/hmg/ddl143 · DOI · Paper page
  142. Hodgson-Zingman, 2008, Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation, N Engl J Med, 359, 158, 10.1056/NEJMoa0706300 · DOI · Paper page
  143. Gollob, 2006, Somatic mutations in the connexin 40 gene (gja5) in atrial fibrillation, N Engl J Med, 354, 2677, 10.1056/NEJMoa052800 · DOI · Paper page
  144. Ellinor, 2010, Common variants in kcnn3 are associated with lone atrial fibrillation, Nat Genet, 42, 240, 10.1038/ng.537 · DOI · Paper page
  145. Maron, 2003, A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines, J Am Coll Cardiol, 42, 1687, 10.1016/S0735-1097(03)00941-0 · DOI · Paper page
  146. Watkins, 1992, Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations, J Clin Invest, 90, 1666, 10.1172/JCI116038 · DOI
  147. Maron, 2007, Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy, Jama, 298, 405, 10.1001/jama.298.4.405 · DOI · Paper page
  148. Thierfelder, 1994, Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere, Cell, 77, 701, 10.1016/0092-8674(94)90054-X · DOI · Paper page
  149. Richard, 2003, Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy, Circulation, 107, 2227, 10.1161/01.CIR.0000066323.15244.54 · DOI · Paper page
  150. Jääskeläinen, 2004, Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes, Ann Med, 36, 23, 10.1080/07853890310017161 · DOI
  151. Geier, 2008, Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy, Hum Mol Genet, 17, 2753, 10.1093/hmg/ddn160 · DOI
  152. Chiu, 2010, Mutations in a-actinin-2 cause hypertrophic cardiomyopathy: a genome-wide analysis, J Am Coll Cardiol, 55, 1127, 10.1016/j.jacc.2009.11.016 · DOI
  153. Niimura, 1998, Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy, N Engl J Med, 338, 1248, 10.1056/NEJM199804303381802 · DOI · Paper page
  154. Watkins, 1995, Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy, N Engl J Med, 332, 1058, 10.1056/NEJM199504203321603 · DOI · Paper page
  155. Van Driest, 2005, Yield of genetic testing in hypertrophic cardiomyopathy, Mayo Clin Proc, 80, 739, 10.4065/80.6.739 · DOI
  156. Andersen, 2009, Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives, Hum Mutat, 30, 363, 10.1002/humu.20862 · DOI
  157. Girolami, 2010, Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations, J Am Coll Cardiol, 55, 1444, 10.1016/j.jacc.2009.11.062 · DOI · Paper page
  158. Ingles, 2005, Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling, J Med Genet, 42, e59, 10.1136/jmg.2005.033886 · DOI · Paper page
  159. Wordsworth, 2010, DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model, Eur Heart J, 31, 926, 10.1093/eurheartj/ehq067 · DOI
  160. Elliott, 2000, Sudden death in hypertrophic cardiomyopathy: identification of high risk patients, J Am Coll Cardiol, 36, 2212, 10.1016/S0735-1097(00)01003-2 · DOI · Paper page
  161. Olivotto, 2008, Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy, Mayo Clin Proc, 83, 630, 10.4065/83.6.630 · DOI · Paper page
  162. Force, 2010, Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute, Circulation, 122, 1130, 10.1161/CIRCULATIONAHA.110.950089 · DOI
  163. Abozguia, 2010, The metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy, Circulation, 122, 1562, 10.1161/CIRCULATIONAHA.109.934059 · DOI · Paper page
  164. Penicka, 2009, The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study, J Mol Diagn, 11, 35, 10.2353/jmoldx.2009.080082 · DOI
  165. Semsarian, 2002, The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model, J Clin Invest, 109, 1013, 10.1172/JCI200214677 · DOI
  166. Teekakirikul, 2010, Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-beta, J Clin Invest, 120, 3520, 10.1172/JCI42028 · DOI · Paper page
  167. Basso, 1999, Cardiovascular causes of sudden death in young individuals including athletes, Cardiol Rev, 7, 127, 10.1097/00045415-199905000-00009 · DOI
  168. Tabib, 2003, Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia, Circulation, 108, 3000, 10.1161/01.CIR.0000108396.65446.21 · DOI · Paper page
  169. Sen-Chowdhry, 2008, Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity, J Am Coll Cardiol, 52, 2175, 10.1016/j.jacc.2008.09.019 · DOI · Paper page
  170. Sen-Chowdhry, 2007, Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression, Circulation, 115, 1710, 10.1161/CIRCULATIONAHA.106.660241 · DOI · Paper page
  171. Marcus, 2010, Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria, Circulation, 121, 1533, 10.1161/CIRCULATIONAHA.108.840827 · DOI · Paper page
  172. Towbin, 2008, Arrhythmogenic right ventricular cardiomyopathy: a paradigm of overlapping disorders, Ann Noninvasive Electrocardiol, 13, 325, 10.1111/j.1542-474X.2008.00241.x · DOI
  173. Sen-Chowdhry, 2010, Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment, Annu Rev Med, 61, 233, 10.1146/annurev.med.052208.130419 · DOI · Paper page
  174. Dalal, 2005, Arrhythmogenic right ventricular dysplasia: a United States experience, Circulation, 112, 3823, 10.1161/CIRCULATIONAHA.105.542266 · DOI · Paper page
  175. Peters, 2004, Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital, Int J Cardiol, 97, 499, 10.1016/j.ijcard.2003.10.037 · DOI
  176. Sen-Chowdhry, 2005, Genetics of right ventricular cardiomyopathy, J Cardiovasc Electrophysiol, 16, 927, 10.1111/j.1540-8167.2005.40842.x · DOI
  177. Dalal, 2006, Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy, J Am Coll Cardiol, 48, 1416, 10.1016/j.jacc.2006.06.045 · DOI
  178. Awad, 2008, Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy, Nat Clin Pract Cardiovasc Med, 5, 258, 10.1038/ncpcardio1182 · DOI · Paper page
  179. Awad, 2006, Recessive arrhythmogenic right ventricular dysplasia due to novel cryptic splice mutation in PKP2, Hum Mutat, 27, 1157, 10.1002/humu.9461 · DOI
  180. McKoy, 2000, Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease), Lancet, 355, 2119, 10.1016/S0140-6736(00)02379-5 · DOI · Paper page
  181. Norgett, 2000, Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma, Hum Mol Genet, 9, 2761, 10.1093/hmg/9.18.2761 · DOI · Paper page
  182. Protonotarios, 2004, Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy, Cardiovasc Pathol, 13, 185, 10.1016/j.carpath.2004.03.609 · DOI
  183. Simpson, 2009, Homozygous mutation of desmocollin-2 in arrhythmogenic right ventricular cardiomyopathy with mild palmoplantar keratoderma and woolly hair, Cardiology, 113, 28, 10.1159/000165696 · DOI
  184. Xu, 2010, Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy, J Am Coll Cardiol, 55, 587, 10.1016/j.jacc.2009.11.020 · DOI · Paper page
  185. Rampazzo, 2002, Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy, Am J Hum Genet, 71, 1200, 10.1086/344208 · DOI · Paper page
  186. Gerull, 2004, Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy, Nat Genet, 36, 1162, 10.1038/ng1461 · DOI · Paper page
  187. Pilichou, 2006, Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy, Circulation, 113, 1171, 10.1161/CIRCULATIONAHA.105.583674 · DOI · Paper page
  188. Syrris, 2006, Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2, Am J Hum Genet, 79, 978, 10.1086/509122 · DOI · Paper page
  189. Asimaki, 2007, A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy, Am J Hum Genet, 81, 964, 10.1086/521633 · DOI · Paper page
  190. Awad, 2006, DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy, Am J Hum Genet, 79, 136, 10.1086/504393 · DOI
  191. Merner, 2008, Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene, Am J Hum Genet, 82, 809, 10.1016/j.ajhg.2008.01.010 · DOI · Paper page
  192. Beffagna, 2005, Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1, Cardiovasc Res, 65, 366, 10.1016/j.cardiores.2004.10.005 · DOI · Paper page
  193. Tiso, 2001, Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2), Hum Mol Genet, 10, 189, 10.1093/hmg/10.3.189 · DOI · Paper page
  194. Corrado, 2006, Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies, Circulation, 113, 1634, 10.1161/CIRCULATIONAHA.105.616490 · DOI
  195. Sen-Chowdhry, 2007, Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy, J Am Coll Cardiol, 50, 1813, 10.1016/j.jacc.2007.08.008 · DOI
  196. van Tintelen, 2006, Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy, Circulation, 113, 1650, 10.1161/CIRCULATIONAHA.105.609719 · DOI · Paper page
  197. Christensen, 2010, Missense variants in plakophilin-2 in arrhythmogenic right ventricular cardiomyopathy patients—disease-causing or innocent bystanders?, Cardiology, 115, 148, 10.1159/000263456 · DOI
  198. Posch, 2008, Variations in DSG2: V56M, V158G and V920G are not pathogenic for arrhythmogenic right ventricular dysplasia/cardiomyopathy, Nat Clin Pract Cardiovasc Med, 5, E1, 10.1038/ncpcardio1434 · DOI
  199. Posch, 2008, A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy, Mol Genet Metab, 95, 74, 10.1016/j.ymgme.2008.06.005 · DOI
  200. Bauce, 2010, Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia, Heart Rhythm, 7, 22, 10.1016/j.hrthm.2009.09.070 · DOI

200 of 264 shown

Cited by

See all 1,479

Metadata

Authors
Ackerman, M. J., Priori, S. G., Willems, S., Berul, C., Brugada, R., Calkins, H., Camm, A. J., Ellinor, P. T., Gollob, M., Hamilton, R., Hershberger, R. E., Judge, D. P., Le Marec, H., McKenna, W. J., Schulze-Bahr, E., Semsarian, C., Towbin, J. A., Watkins, H., Wilde, A., Wolpert, C., & Zipes, D. P.
Venue
Heart Rhythm
Publisher
Elsevier BV
Published
2011-08
Volume
8
Issue
8
Pages
1308-1339
ISSN
1547-5271 (ISSN-L)
DOI
10.1016/j.hrthm.2011.05.020
OpenAlex
W1993190948
Cited by
1,479
References
13
FWCI
77.52
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.